Ditchcarbon
  • Contact
  1. Organizations
  2. Ferring B.V.
Public Profile
Pharmaceutical Preparation Manufacturing
NL
updated 2 months ago

Ferring B.V. Sustainability Profile

Company website

Ferring B.V., a global biopharmaceutical company headquartered in the Netherlands, is renowned for its innovative solutions in reproductive health, urology, and gastroenterology. Founded in 1950, Ferring has established a strong presence in key operational regions, including Europe, North America, and Asia, focusing on developing and manufacturing advanced therapies that address unmet medical needs. The company’s core products, such as hormone therapies and treatments for gastrointestinal disorders, are distinguished by their commitment to patient-centric care and scientific excellence. Ferring's dedication to research and development has positioned it as a leader in the biopharmaceutical industry, with notable achievements in expanding access to essential medicines worldwide. Through its pioneering approach, Ferring B.V. continues to make significant contributions to healthcare, enhancing the quality of life for patients globally.

DitchCarbon Score

How does Ferring B.V.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

30

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Ferring B.V.'s score of 30 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.

55%

Let us know if this data was useful to you

Ferring B.V.'s reported carbon emissions

Ferring B.V., headquartered in the Netherlands, currently does not report specific carbon emissions data for the most recent year, as indicated by the absence of emissions figures. The company is a current subsidiary of Ferring Holding SA, which may influence its climate commitments and reporting practices. Ferring B.V. has not outlined any specific reduction targets or initiatives in its climate strategy. However, it is important to note that the company is part of a broader corporate family that may have established climate commitments. The emissions data and reduction targets may be cascaded from Ferring Holding SA, which could provide insights into the company's overall climate strategy. As of now, Ferring B.V. has not publicly committed to any specific climate pledges or initiatives such as the Science Based Targets initiative (SBTi) or the Carbon Disclosure Project (CDP). The absence of detailed emissions data and reduction targets suggests that Ferring B.V. may still be in the process of developing its climate action framework. In summary, while Ferring B.V. does not currently report specific emissions data or reduction targets, its affiliation with Ferring Holding SA may play a role in shaping its future climate commitments.

How Carbon Intensive is Ferring B.V.'s Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ferring B.V.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Ferring B.V.'s Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Ferring B.V. is in NL, which has a very low grid carbon intensity relative to other regions.

Ferring B.V.'s Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Ferring B.V. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Ferring B.V.'s Emissions with Industry Peers

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 15 days ago

Anika Therapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Avanos Medical, Inc.

US
•
Health and social work services (85)
Updated about 2 months ago

Juniper Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 2 months ago

Swedish Orphan Biovitrum

SE
•
Pharmaceutical Preparation Manufacturing
Updated about 14 hours ago

Watson Laboratories, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 19 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251031.5
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy